Latest filing published 04 Apr 2017 for NxStage Medical, Inc., €174k.
Filing timeline
BuySaleInsider track record
Robert S. Brown: trading record in brief
Robert S. Brown discloses dealings in NxStage Medical, Inc. to SEC (Form 4). The record holds 149 filings, for trades running from 3 March 2010 to 3 April 2017.
Sales make up the whole of the open-market record (57 sales, €11.4M). Outside the open market, there are 22 share grants and 70 option exercises. Since January 2017: no purchases and 18 sales on the market.
The record was last updated on 4 April 2017 with an option exercise (€174k) in NxStage Medical, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Robert S. Brown
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 11,917 shares@ US$15.582.7% of flowCommon StockSEC:0001246360-17-001558:0
- 14,397 shares@ US$26.605.6% of flowCommon StockSEC:0001246360-17-001558:1
- 20,000 shares@ US$16.664.9% of flowCommon StockSEC:0001246360-17-001251:0
- 20,000 shares@ US$27.758.2% of flowCommon StockSEC:0001246360-17-001251:1
- 4,586 shares@ US$28.311.9% of flowCommon StockSEC:0001246360-17-001214:1
- 6,390 shares@ US$28.012.6% of flowCommon StockSEC:0001246360-17-001214:2
- 9,747 shares0Common StockSEC:0001246360-17-001214:0
- 2,448 shares@ US$28.281.0% of flowCommon StockSEC:0001246360-17-000752:0
- 3,054 shares@ US$27.611.2% of flowCommon StockSEC:0001246360-17-000491:0
- 3,117 shares@ US$27.541.2% of flowCommon StockSEC:0001246360-17-000462:0
- 13,000 shares@ US$14.662.8% of flowCommon StockSEC:0001246360-17-000452:0
- 13,000 shares@ US$26.775.0% of flowCommon StockSEC:0001246360-17-000452:1
- 3,283 shares@ US$27.291.3% of flowCommon StockSEC:0001246360-17-000452:2
- 13,000 shares@ US$14.662.7% of flowCommon StockSEC:0001246360-17-000417:0
- 19,602 shares@ US$26.657.5% of flowCommon StockSEC:0001246360-17-000417:1
- 13,000 shares@ US$14.662.8% of flowCommon StockSEC:0001246360-17-000417:2
- 17,745 shares@ US$26.726.9% of flowCommon StockSEC:0001246360-17-000417:3
- 15,000 shares@ US$11.032.4% of flowCommon StockSEC:0001246360-17-000341:0
- 15,000 shares@ US$25.865.6% of flowCommon StockSEC:0001246360-17-000341:1
- 20,000 shares@ US$11.033.2% of flowCommon StockSEC:0001246360-17-000341:2
- 20,000 shares@ US$26.137.6% of flowCommon StockSEC:0001246360-17-000341:3
- 7,000 shares@ US$11.031.1% of flowCommon StockSEC:0001246360-17-000341:4
- 7,000 shares@ US$26.252.7% of flowCommon StockSEC:0001246360-17-000341:5
- 6,415 shares@ US$27.232.6% of flowCommon StockSEC:0001246360-17-000246:0
- 200 shares@ US$27.910.1% of flowCommon StockSEC:0001246360-17-000246:1
25 of 147 declarations